| scholarly article | Q13442814 |
| P50 | author | Matthias Niedrig | Q28152070 |
| P2093 | author name string | Karen Sonnenberg | |
| Christian Herzog | |||
| Oliver Kürsteiner | |||
| P2860 | cites work | Neutralizing and haemagglutination-inhibiting antibodies to yellow fever 17 years after vaccination with 17D vaccine | Q27486983 |
| Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases. | Q34516465 | ||
| A Belgian traveler who acquired yellow fever in the Gambia | Q38950294 | ||
| Yellow fever vaccine-associated viscerotropic disease and death in Spain. | Q40336277 | ||
| Comparison of ELISA and immunoassays for measurement of IgG and IgM antibody to West Nile virus in human sera against virus neutralisation. | Q40465536 | ||
| Analysis of two imported cases of yellow fever infection from Ivory Coast and The Gambia to Germany and Belgium | Q40503066 | ||
| Immunogenicity and safety of BERNA-YF compared with two other 17D yellow fever vaccines in a phase 3 clinical trial. | Q40512856 | ||
| Gender differences in the reactogenicity of measles-mumps-rubella vaccine | Q40623009 | ||
| Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA. | Q40627603 | ||
| Comparison of the immunogenicity and safety of two 17D yellow fever vaccines. | Q40636331 | ||
| Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis | Q40674766 | ||
| Comparison of the Enzyme-Linked Immunosorbent Assay (Elisa) with Standard Tests used to Detect Yellow Fever Virus Antibodies * | Q40836537 | ||
| Indirect fluorescent antibody test for the diagnosis of yellow fever | Q40856674 | ||
| The haemagglutination-inhibition test in the diagnosis of yellow fever in man. | Q41034759 | ||
| Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection | Q42990104 | ||
| The effect of testosterone on cytokine production in the specific and non-specific immune response | Q45114642 | ||
| Rational histochemistry using a new microanalytic technic | Q69956929 | ||
| Yellow fever situation in Africa and South America, 2005 | Q80150275 | ||
| P433 | issue | 2 | |
| P921 | main subject | antibody | Q79460 |
| yellow fever | Q154874 | ||
| immunofluorescence microscopy | Q592324 | ||
| yellow fever virus | Q836749 | ||
| clinical chemistry | Q849994 | ||
| P304 | page(s) | 177-81 | |
| P577 | publication date | 2008-02-01 | |
| P1433 | published in | Clinical and Vaccine Immunology | Q5133811 |
| P1476 | title | Evaluation of an Indirect Immunofluorescence Assay for Detection of Immunoglobulin M (IgM) and IgG Antibodies against Yellow Fever Virus | |
| P478 | volume | 15 |
| Q35629136 | A novel immunochromatographic test applied to a serological survey of Japanese encephalitis virus on pig farms in Korea |
| Q38080334 | Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010. |
| Q59245624 | Analysis of Zika virus neutralizing antibodies in normal healthy Thais |
| Q51498320 | Anti-early endosome antigen 1 autoantibodies were detected in a pemphigus-like patient but not in the majority of pemphigus diseases. |
| Q39592224 | Comparison of the PRNT and an immune fluorescence assay in yellow fever vaccinees receiving immunosuppressive medication |
| Q35246149 | Description of a prospective 17DD yellow fever vaccine cohort in Recife, Brazil |
| Q47550078 | Development and Validation of a Serologic Test Panel for Detection of Powassan Virus Infection in U.S. Patients Residing in Regions Where Lyme Disease Is Endemic |
| Q38322970 | Diagnostic potential and antigenic properties of recombinant tick-borne encephalitis virus subviral particles expressed in mammalian cells from Semliki Forest virus replicons |
| Q102387839 | Duration of seropositivity following yellow fever vaccination in U.S. military service members |
| Q37166091 | Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years. |
| Q39684793 | Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development |
| Q35919750 | Fluorescence Adherence Inhibition Assay: A Novel Functional Assessment of Blocking Virus Attachment by Vaccine-Induced Antibodies |
| Q34770828 | Immune response during adverse events after 17D-derived yellow fever vaccination in Europe |
| Q50004449 | Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak - Preliminary Report |
| Q34593000 | Influenza virus-specific neutralizing IgM antibodies persist for a lifetime |
| Q57131014 | Japanese Encephalitis: A Brief Review on Indian Perspectives |
| Q43040482 | Rapid detection of Tembusu virus by reverse-transcription, loop-mediated isothermal amplification (RT-LAMP). |
| Q39200155 | Serologic assessment of yellow fever immunity in the rural population of a yellow fever-endemic area in Central Brazil |
| Q58610010 | The Neglect and Fast Spread of Some Arboviruses: A Note for Healthcare Providers in Nigeria |
| Q57168259 | What Does the Future Hold for Yellow Fever Virus? (II) |
| Q59356551 | Yellow Fever Virus: Diagnostics for a Persistent Arboviral Threat |
| Q56000581 | Yellow fever in the diagnostics laboratory |
| Q40356845 | Yellow fever revaccination during infliximab therapy |
Search more.